CN117085097A - 一种预防与治疗皮肤皴裂的中药组合物及其中药制品 - Google Patents
一种预防与治疗皮肤皴裂的中药组合物及其中药制品 Download PDFInfo
- Publication number
- CN117085097A CN117085097A CN202311173415.4A CN202311173415A CN117085097A CN 117085097 A CN117085097 A CN 117085097A CN 202311173415 A CN202311173415 A CN 202311173415A CN 117085097 A CN117085097 A CN 117085097A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- chinese medicine
- parts
- medicinal
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 88
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 241000755540 Indocalamus Species 0.000 claims abstract description 26
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 20
- 239000009136 dragon's blood Substances 0.000 claims abstract description 20
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 19
- 244000235603 Acacia catechu Species 0.000 claims abstract description 19
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 19
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 19
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 19
- 238000001816 cooling Methods 0.000 claims abstract description 16
- 240000004980 Rheum officinale Species 0.000 claims abstract description 14
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 14
- 229940126680 traditional chinese medicines Drugs 0.000 claims abstract description 6
- 239000003921 oil Substances 0.000 claims description 32
- 235000019198 oils Nutrition 0.000 claims description 32
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 22
- 239000002994 raw material Substances 0.000 claims description 12
- 229910052742 iron Inorganic materials 0.000 claims description 11
- 239000008159 sesame oil Substances 0.000 claims description 11
- 235000011803 sesame oil Nutrition 0.000 claims description 11
- 229940099259 vaseline Drugs 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 238000007873 sieving Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 239000002674 ointment Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 4
- 239000000919 ceramic Substances 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000004939 coking Methods 0.000 claims 1
- 230000001376 precipitating effect Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 31
- 210000004369 blood Anatomy 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 20
- 208000002193 Pain Diseases 0.000 abstract description 18
- 230000017531 blood circulation Effects 0.000 abstract description 16
- 229940079593 drug Drugs 0.000 abstract description 15
- 230000000740 bleeding effect Effects 0.000 abstract description 10
- 241000219061 Rheum Species 0.000 abstract description 6
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 5
- 239000002671 adjuvant Substances 0.000 abstract description 4
- 230000008439 repair process Effects 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 241001671204 Stemona Species 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 206010040849 Skin fissures Diseases 0.000 abstract description 2
- 230000003467 diminishing effect Effects 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 description 16
- 208000032843 Hemorrhage Diseases 0.000 description 8
- 235000019640 taste Nutrition 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 208000034507 Haematemesis Diseases 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000015817 Infant Nutrition disease Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 239000003245 coal Substances 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 239000009286 sanguis draxonis Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010057009 Pharyngeal erythema Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000448536 Pyrrholaemus brunneus Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000010515 dystocia Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 201000004169 miliaria rubra Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 206010035653 pneumoconiosis Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药技术领域,具体涉及一种预防与治疗皮肤皴裂的中药组合物及其中药制品,包括箬兰、血竭、大黄、儿茶、苦参、百部与红花。箬兰为君药,主要功效是清热凉血,也有收敛止血的作用。血竭、大黄、儿茶为臣药,它们在配伍中起到协同作用,共同增强皮肤的血液循环和修复功能。苦参、百部、红花为佐药,它们在配伍中能够增强箬兰的清热、燥湿、活血和止痛作用。各药物组方之间配伍作用主要围绕散瘀活血、清热凉血、止痛、消炎和收敛止血等方面展开。各组分相互协同,使药物的疗效相互增强,从而达到预防和治疗皮肤皲裂的目的。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种预防与治疗皮肤皴裂的中药组合物及其中药制品。
背景技术
由于冬季寒冷、干燥,汗液分泌较少,皮肤表面缺少皮脂滋润,手掌处,手指背面及曲侧,足跟等地方,由于长时间运动或摩擦、接触碱性洗涤剂或溶液等,容易引起皮肤表面出现长短不一,深浅不等的裂缝,过深的裂痕会有血渗出,疼痛感剧烈。
裂痕又称皴裂,为冬季临床常见皮肤病症状,伴随有瘙痒和疼痛感,在建筑劳动者,农业从业者,渔业从业者和老年人群中发生率较高,给这一群体的工作和生活带来较大烦恼和身体折磨。
目前市面上用于皴裂的药品较多,但大多以凡士林直接涂抹皮肤表面进行保护,口服维生素等方法进行处理,以中药为组分,兼具保护与治疗为一体的药膏极为少见,结合中医医养一体的理念,深层次改善皮肤表面环境,促进体表血液循环,修复受损肌肤,保护脆弱皮肤不再受损。
本发明所面对患者主要集中贵州省纳雍县和七星关区两个县区,总体表征为每年进入11月底直至次年4月,贵州省西北部阴湿天气多,基本整个冬天鲜见太阳,农业从业人员常年在外劳作,天黑返家后取暖又多以煤炭火炉为主,加之该区域属于高硫矿区,导致随时冷湿的手足,在煤火炉旁边一烤,手足极易皴裂,且伤口愈合难度极大。
基于以上现状,研制一种基于中医医疗理念,以中药组分为核心,兼具杀虫止痒,促进体表血液循环,受损皮肤恢复为主的外用预防、治疗皴裂的护肤药品,具有极大的现实意义。
发明内容
本发明的目的在于提供一种预防与治疗皮肤皴裂的中药组合物及其中药制品,无刺激、无毒副作用,对治疗冬季手足皴裂、皮肤伤口愈合等具有良好疗效。
为实现上述技术目的,达到上述技术效果,本发明是通过以下技术方案实现:
一种预防与治疗皮肤皴裂的中药组合物,所述中药组合物包括箬兰、血竭、大黄、儿茶、苦参、百部与红花。
进一步的,所述中药组合物的原料重量份配比为:箬兰7-14份,血竭8-11份,大黄3-5份,儿茶7-9份,苦参4-7份,百部4-7份,红花3-5份。
进一步的,所述中药组合物的原料重量份配比为:箬兰12份、血竭9份、大黄4份、儿茶7份、苦参5份、百部6份、红花4份。
另一方面,本发明提出一种预防与治疗皮肤皴裂的中药制品,所述中药制品是由上述的中药组合物制得的外用药剂。
进一步的,所述外用药剂包括但不限于膏剂、油剂、乳剂、霜剂与喷剂。
进一步的,所述膏剂的制备包括以下步骤:
S1:将中药组合物中各类中药按比例充分混合后,置于真空干燥箱中干燥;
S2:将经过干燥后的中药组分,用粉碎机进行粉碎,过40目筛网,筛剩下的组分,继续粉碎过筛直至全部过筛;
S3:将经过粉碎过筛后的中药组分置于陶瓷罐中或铁罐中,加入100份的麻油,搅匀,加盖密封进行浸泡,每隔24小时搅动一次,使麻油始终浸润中药组分,浸泡时间5天,至麻油完全浸透;
S4:将浸泡好的中药组分和麻油一并倒入铁锅中进行药物油熬制,以液化炉为熬制灶具,大火起锅,待油温升起,能观察到药物组份开始出现变色,转为小火继续熬制,熬制药物组分颗粒大部分沉淀、焦化,以手捻颗粒即碎时停止,熬制时间2-3小时;
S5:将熬制好的药油冷却,纱布过滤掉药渣,剩余药油重新置于铁锅中加热,文火熬制进行药油浓缩,熬至药油滴入水中不散开即可,浓缩时间为0-1小时;
S6:将浓缩好的药油置于一旁冷却至70-80°备用,重新用铁锅融化凡士林,温度70-80°,待凡士林完全融化后,等体积比例倒入药油,充分搅匀凡士林与药油混合物;
S7:取消毒后的广口瓶子倒入混合药油,冷却至常温存储备用,即得膏剂中药制品。
血竭:性味:甘、咸,平;归心经、肝经;主治:散瘀定痛,止血生肌。治跌打折损,内伤瘀痛;外伤出血不止,瘰疬,臁疮溃久不合。《唐本草》:主五脏邪气,带下,止痛,破积血,金创生肉。
箬兰:性味:微寒,苦、甘、涩;归肺、肝、胃经;主治:治咳血吐血、肺结核咳血、溃疡病出血,止肺血,治矽肺,有收敛止血,消肿生肌之功,用于内外出血诸证及痈肿、烫伤、手足皲裂、肛裂等。《本经》:主痈肿恶疮败疽,伤阴死肌,胃中邪气,贼风痱缓不收。
大黄:性味:苦,寒;入胃经、大肠经、肝经;主治:泻热毒,破积滞,行瘀血。治实热便秘,谵语,食积痞满,痢疾初起,里急后重,瘀停经闭,癥瘕积聚,时行热疫,暴眼赤痛,吐血,衄血,阳黄,水肿,淋浊,痈疡肿毒,疔疮,汤火伤。《本经》:下瘀血,血闭,寒热,破癥瘕积聚,留饮宿食,荡涤肠胃,推陈致新,通利水谷,调中化食,安和五脏。
儿茶:性味:苦涩;凉;无毒;归心经、肺经;主治:清热化痰,消食,活血疗伤,止血生肌,敛疮。治痰热咳嗽,消渴,吐血,衄血,尿血,血痢,血崩,小儿消化不良,牙疳,口疮,喉痹,湿疮。《本草正》:降火生津,清痰涎咳嗽,治口疮喉痹,烦热,止消渴,吐血,衄血,便血,尿血,湿热痢血,及妇人崩淋,经血不止,小儿疳热,口疳,热疮,湿烂诸疮,敛肌长肉,亦杀诸虫。
苦参:性味:味苦;性寒;肝经;肾经;大肠经;胃经;主治:清热,燥湿,杀虫。治热毒血痢,肠风下血,黄疸,赤白带下,小儿肺炎,疳积,急性扁桃体炎,痔漏,脱肛,皮肤瘙痒,疥癞恶疮,阴疮湿痒,瘰疬,烫伤。外治滴虫性阴道炎。《药性论》:治热毒风,皮肌烦燥生疮,赤癞眉脱,主除大热嗜睡,治腹中冷痛,中恶腹痛,除体闷,治心腹积聚。
百部:性味:甘苦,微温;入肺经;主治:温润肺气,止咳,杀虫。治风寒咳嗽,百日咳,肺结核,老年咳喘,蛔虫、蛲虫病,皮肤疥癣、湿疹。《本草拾遗》:火炙浸酒空腹饮,去虫蚕咬,兼疥癣疮。
红花:性味:辛,温;入心经、肝经;主治:活血通经,去瘀止痛。治经闭,癥瘕,难产,死胎,产后恶露不行、瘀血作痛,痈肿,跌扑损伤。《纲目》:活血,润燥,止痛,散肿,通经。
本发明的有益效果:
本发明提出的一种预防与治疗皮肤皴裂的中药组合物及其中药制品,具有杀虫、杀菌、止痒、活血、敛疮等功效。原料为全中药组合,刺激性小,无毒副作用,治愈率高,用药禁忌小等优势。本发明严格按照中医用药配伍进行搭配,其中箬兰为君药用于收敛,血竭、大黄、儿茶为臣药用于增强皮肤的血液循环和修复功能,苦参、百部、红花为佐药用于增强箬兰的清热、燥湿、活血和止痛作用,同时血竭用于散瘀定痛、止血生肌,大黄具有泻热毒、破积滞、行瘀血。
箬兰为君药,主要功效是清热凉血,也有收敛止血的作用。
血竭、大黄、儿茶为臣药,它们在配伍中起到协同作用,共同增强皮肤的血液循环和修复功能。
苦参、百部、红花为佐药,它们在配伍中能够增强箬兰的清热、燥湿、活血和止痛作用。
血竭具有散瘀定痛、止血生肌的作用,而大黄具有泻热毒、破积滞、行瘀血的作用。二者配伍能够协同作用,加强散瘀活血的效果,能够改善皮肤的血液循环,促进裂纹的修复。
箬兰具有清热凉血、收敛止血的作用,大黄具有泻热毒、破积滞、行瘀血的作用。二者配伍能够协同清热凉血的作用,对于皮肤湿热、瘀血等问题有较好的疗效;苦参具有清热、燥湿、杀虫的作用。与箬兰配伍能够协同消炎的作用,对于皮肤炎症和瘙痒症状有辅助治疗作用;红花具有活血通经、去瘀止痛的作用,与箬兰配伍能够协同止痛的作用,可以改善皮肤瘀血引起的疼痛感。血竭与大黄的配伍箬兰,可以合力散瘀、破积滞,加速血液循环,促进皮肤修复。
总结起来,本药方中的各药物组方之间配伍作用主要围绕散瘀活血、清热凉血、止痛、消炎和收敛止血等方面展开。它们能够相互协同,使药物的疗效相互增强,从而达到预防和治疗皮肤皲裂的目的。
当然,实施本发明的任一产品并不一定需要同时达到以上所述的所有优点。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。
实施例1
本实施例所述的一种预防与治疗皮肤皴裂的中药组合物,所述中药组合物包括箬兰、血竭、大黄、儿茶、苦参、百部与红花。
在本实施例中,所述中药组合物的原料重量份配比为:箬兰7-14份,血竭8-11份,大黄3-5份,儿茶7-9份,苦参4-7份,百部4-7份,红花3-5份。
另一方面,本发明提出一种预防与治疗皮肤皴裂的中药制品,所述中药制品是由上述的中药组合物制得的外用药剂。
在本实施例中,所述外用药剂包括但不限于膏剂、油剂、乳剂、霜剂与喷剂。
在本实施例中,所述膏剂的制备包括以下步骤:
S1:将中药组合物中各类中药按比例充分混合后,置于真空干燥箱中干燥;
S2:将经过干燥后的中药组分,用粉碎机进行粉碎,过40目筛网,筛剩下的组分,继续粉碎过筛直至全部过筛;
S3:将经过粉碎过筛后的中药组分置于陶瓷罐中或铁罐中,加入100份的麻油,搅匀,加盖密封进行浸泡,每隔24小时搅动一次,使麻油始终浸润中药组分,浸泡时间5天,至麻油完全浸透;
S4:将浸泡好的中药组分和麻油一并倒入铁锅中进行药物油熬制,以液化炉为熬制灶具,大火起锅,待油温升起,能观察到药物组份开始出现变色,转为小火继续熬制,熬制药物组分颗粒大部分沉淀、焦化,以手捻颗粒即碎时停止,熬制时间2-3小时;
S5:将熬制好的药油冷却,纱布过滤掉药渣,剩余药油重新置于铁锅中加热,文火熬制进行药油浓缩,熬至药油滴入水中不散开即可,浓缩时间为0-1小时;
S6:将浓缩好的药油置于一旁冷却至70-80°备用,重新用铁锅融化凡士林,温度70-80°,待凡士林完全融化后,等体积比例倒入药油,充分搅匀凡士林与药油混合物;
S7:取消毒后的广口瓶子倒入混合药油,冷却至常温存储备用,即得膏剂中药制品。
实施例2
本实施例所述的一种预防与治疗皮肤皴裂的中药组合物,所述中药组合物包括箬兰、血竭、大黄、儿茶、苦参、百部与红花。
在本实施例中,所述中药组合物的原料重量份配比为:所述中药组合物的原料重量份配比为:箬兰12份、血竭9份、大黄4份、儿茶7份、苦参5份、百部6份、红花4份。
实施例3
本实施例所述的一种预防与治疗皮肤皴裂的中药组合物,所述中药组合物包括箬兰、血竭、大黄、儿茶、苦参、百部与红花。
在本实施例中,所述中药组合物的原料重量份配比为:所述中药组合物的原料重量份配比为:箬兰11份、血竭8份、大黄3份、儿茶6份、苦参4份、百部5份、红花3份。
实施例4
本实施例所述的一种预防与治疗皮肤皴裂的中药组合物,所述中药组合物包括箬兰、血竭、大黄、儿茶、苦参、百部与红花。
在本实施例中,所述中药组合物的原料重量份配比为:所述中药组合物的原料重量份配比为:箬兰13份、血竭10份、大黄5份、儿茶8份、苦参6份、百部7份、红花5份。
实施例5
临床试验:
选择手足皴裂患者61人,其中手皴裂患者57人,足跟皴裂患者11人,手、足均皴裂者10人,患者主要集中贵州省纳雍县和七星关区两个县区,总体表征为每年进入11月底直至次年4月,贵州省西北部阴湿天气多,基本整个冬天鲜见太阳,农业从业人员常年在外劳作,天黑返家后取暖又多以煤炭火炉为主,加之该区域属于高硫矿区,导致随时冷湿的手足,在煤火炉旁边一烤,手足极易皴裂,且伤口愈合难度极大。
按照实施例2得到的预防、治疗皮肤皴裂的中药组合物,对患者进行施药,每日4次用药,分别为早上,中午,傍晚,睡前,连续使用7天为一疗程,使用3个疗程即停药。
疗效判定标准:
治愈:经过2-3疗程用药后,皮肤病症消失,表征正常,表面恢复正常光泽;
显效:经过2-3疗程用药后,皮肤病症减轻,皴裂痕缓慢愈合;
无效:经过2-3疗程用药后,皮肤病症无变化或加重;
治疗结果:
经过2-3疗程治疗后,其中手皴裂患者治愈49例,显效7例,无效5例,手皴裂总有效率91.8%,;足皴裂患者治愈10例,显效0例,无效1例,总有效率90.9%;手足均皴裂患者治愈7例,显效1例,无效2例,总有效率80%。
以上公开的本发明优选实施例只是用于帮助阐述本发明。优选实施例并没有详尽叙述所有的细节,也不限制该发明仅为所述的具体实施方式。显然,根据本说明书的内容,可作很多的修改和变化。本说明书选取并具体描述这些实施例,是为了更好地解释本发明的原理和实际应用,从而使所属技术领域技术人员能很好地理解和利用本发明。本发明仅受权利要求书及其全部范围和等效物的限制。
Claims (6)
1.一种预防与治疗皮肤皴裂的中药组合物,其特征在于,所述中药组合物包括箬兰、血竭、大黄、儿茶、苦参、百部与红花。
2.如权利要求1所述的中药组合物,其特征在于:所述中药组合物的原料重量份配比为:箬兰7-14份,血竭8-11份,大黄3-5份,儿茶7-9份,苦参4-7份,百部4-7份,红花3-5份。
3.如权利要求2所述的中药组合物,其特征在于:所述中药组合物的原料重量份配比为:箬兰12份、血竭9份、大黄4份、儿茶7份、苦参5份、百部6份、红花4份。
4.一种预防与治疗皮肤皴裂的中药制品,其特征在于,所述中药制品是由权利要求1-3任一项所述的中药组合物制得的外用药剂。
5.如权利要求4所述的中药制品,其特征在于:所述外用药剂包括但不限于膏剂、油剂、乳剂、霜剂与喷剂。
6.如权利要求5所述的中药制品,其特征在于:所述膏剂的制备包括以下步骤:
S1:将中药组合物中各类中药按比例充分混合后,置于真空干燥箱中干燥;
S2:将经过干燥后的中药组分,用粉碎机进行粉碎,过40目筛网,筛剩下的组分,继续粉碎过筛直至全部过筛;
S3:将经过粉碎过筛后的中药组分置于陶瓷罐中或铁罐中,加入100份的麻油,搅匀,加盖密封进行浸泡,每隔24小时搅动一次,使麻油始终浸润中药组分,浸泡时间5天,至麻油完全浸透;
S4:将浸泡好的中药组分和麻油进行药物油熬制,药物组份开始出现变色后由大火转为小火继续熬制,熬制药物组分颗粒大部分沉淀、焦化,以手捻颗粒即碎时停止,熬制时间2-3小时;
S5:将熬制好的药油冷却,纱布过滤掉药渣,剩余药油重新置于铁锅中加热,文火熬制进行药油浓缩,熬至药油滴入水中不散开即可,浓缩时间为0-1小时;
S6:将浓缩好的药油置于一旁冷却至70-80°备用,重新用铁锅融化凡士林,温度70-80°,待凡士林完全融化后,等体积比例倒入药油,充分搅匀凡士林与药油混合物;
S7:取消毒后的广口瓶子倒入混合药油,冷却至常温存储备用,即得膏剂中药制品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311173415.4A CN117085097A (zh) | 2023-09-12 | 2023-09-12 | 一种预防与治疗皮肤皴裂的中药组合物及其中药制品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311173415.4A CN117085097A (zh) | 2023-09-12 | 2023-09-12 | 一种预防与治疗皮肤皴裂的中药组合物及其中药制品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117085097A true CN117085097A (zh) | 2023-11-21 |
Family
ID=88776887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311173415.4A Pending CN117085097A (zh) | 2023-09-12 | 2023-09-12 | 一种预防与治疗皮肤皴裂的中药组合物及其中药制品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117085097A (zh) |
-
2023
- 2023-09-12 CN CN202311173415.4A patent/CN117085097A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102327478A (zh) | 一种治疗烧烫伤的药物组合物及其制备方法 | |
CN101204529A (zh) | 治疗疮伤和消瘢的药物 | |
CN104857290A (zh) | 一种治疗烧烫伤的中药消毒膏及其制备方法 | |
CN102357164B (zh) | 一种临床护理烧伤的药物组合物及其制备方法 | |
CN101850092A (zh) | 一种治疗外伤的药物及其制备方法 | |
CN105168091A (zh) | 一种祛红血丝面膜粉及其制备方法 | |
CN117085097A (zh) | 一种预防与治疗皮肤皴裂的中药组合物及其中药制品 | |
CN103417781A (zh) | 一种治疗外科伤口的中药 | |
CN101406579B (zh) | 半夏的新用途 | |
CN104997945A (zh) | 一种治疗膀胱炎的中药 | |
CN101209338B (zh) | 一种治疗皮肤血管瘤的中药药物 | |
CN103550621B (zh) | 一种快速治疗酒渣鼻的中药制剂 | |
CN115154550B (zh) | 一种治疗溃疡型淋巴结结核的外用中药组合物 | |
CN105456708B (zh) | 一种用于治疗口唇炎的药物及其制备方法 | |
CN110051819A (zh) | 一种用于治疗咳嗽的膏药 | |
CN104306734B (zh) | 治疗糖尿病坏疽外用膏药制剂及其制备方法 | |
CN116570649B (zh) | 一种治疗皮肤粘膜溃疡的多功能中药组合物及制备方法 | |
CN114159536B (zh) | 药物组合物及其制备方法和应用 | |
CN110013513B (zh) | 一种治疗风湿骨痛的外用凝胶及其制备方法 | |
CN109908312B (zh) | 一种痔疮膏及其制备方法 | |
CN101564510A (zh) | 一种有效治疗鹅掌风的中药擦剂 | |
CN119258139A (zh) | 一种促进毛细血管修复、增加细胞活性的中药膏 | |
CN105412416A (zh) | 一种风湿性关节炎的中药洗剂及其制备方法 | |
CN105362944A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
CN105213658A (zh) | 一种治疗过敏性湿疹的中药洗剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |